The US Host Cell Contaminant Testing Market Volume is set to witness substantial growth, projected to increase from USD 86.46 million in 2024 to an estimated USD 245.42 million by 2035. This remarkable growth underscores the expanding significance of testing protocols in the biopharmaceutical industry, where ensuring product integrity is paramount. As companies strive to maintain compliance...